Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02555527 · ClinicalTrials.gov registry record
Contrast Echocardiography Cost Effectiveness for Left Ventricular Thrombus Assessment
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 500,000
- Enrollment target
NCT02555527 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 500,000 participants.
The verdict
NCT02555527 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 500,000 participants
- Enrollment target
Study Summary
To perform a cost-effectiveness analysis for the routine use of contrast in rest echocardiography in patients with dilated or ischemic cardiomyopathy from the United States healthcare system, provider and payer perspectives.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500,000 participants |
| Start Date | 2015-09 |
| Est. Completion | 2017-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02555527
The ClinicalTrials.gov registry entry for NCT02555527 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 500,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02555527 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02555527 about?
NCT02555527 is a clinical study titled "Contrast Echocardiography Cost Effectiveness for Left Ventricular Thrombus Assessment". To perform a cost-effectiveness analysis for the routine use of contrast in rest echocardiography in patients with dilated or ischemic cardiomyopathy from the United States healthcare system, provider and payer perspectives.
What is the current status of trial NCT02555527?
This trial is currently completed. The enrollment target is 500,000 participants. The study started on 2015-09. Estimated completion is 2017-02.
Who is sponsoring clinical trial NCT02555527?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.